Aligos Therapeutics, Inc. - Common stock (NQ:ALGS)

5.370 -0.170 (-3.07%)

Delayed Quote Updated: 10:06 AM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Aligos Therapeutics, Inc. - Common stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

12 Health Care Stocks Moving In Friday's Intraday Session ↗

January 07, 2022

Gainers Absci (NASDAQ:ABSI) stock increased by 28.2% to $7.87 during Friday's regular session. As of 12:30 EST, Absci's stock is trading at a volume of 38.6...

Via Benzinga

33 Stocks Moving In Friday's Mid-Day Session ↗

January 07, 2022

Gainers Marin Software Incorporated (NASDAQ: MRIN) shares climbed 35.9% to $4.6899 after the company announced an integration with Amazon Ads' demand-side platform. Absci...

Via Benzinga

Mid-Afternoon Market Update: Gold Drops 2%; Berkeley Lights Shares Plummet ↗

January 06, 2022

Toward the end of trading Thursday, the Dow traded down 0.35% to 36,278.43 while the NASDAQ rose 0.22% to 15,133.94. The S&P also rose 0.14% to 4,707.37. The U.S. has the...

Via Benzinga

The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO ↗

August 05, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 4) Absci, CORP (NASDAQ: ABSI) (...

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

January 07, 2022

Before 10 am on Friday, 110 companies set new 52-week lows. Interesting Points From Today's 52-Week Lows: Humana (NYSE:HUM) was the biggest company on a market cap...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For January 7, 2022 ↗

January 07, 2022

Upgrades According to Wolfe Research, the prior rating for CVR Energy Inc (NYSE:

Via Benzinga

58 Biggest Movers From Yesterday ↗

January 07, 2022

Gainers Eargo, Inc. (NASDAQ: EAR) shares climbed 59.7% to close at $7.28 on Thurs after the company announced the Department of Justice confirmed to it that the previously-...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

January 06, 2022

Gainers Eargo (NASDAQ:EAR) stock increased by 50.0% to $6.84 during Thursday's regular session. The current volume of 90.4 million shares is 5474.6% of Eargo's...

Via Benzinga

Mid-Day Market Update: Nasdaq Turns Higher; Vocera Communications Shares Surge ↗

January 06, 2022

Midway through trading Thursday, the Dow traded down 0.34% to 36,284.59 while the NASDAQ rose 0.18% to 15,127.00. The S&P, however, rose 0.07% to 4,703.93. The U.S. has the...

Via Benzinga

33 Stocks Moving In Thursday's Mid-Day Session ↗

January 06, 2022

Gainers Eargo, Inc. (NASDAQ: EAR) shares jumped 50.8% to $6.88 after the company announced the Department of Justice confirmed to it that the previously-announced criminal probe...

Via Benzinga

Mid-Morning Market Update: Markets Open Lower; Walgreens Tops Q1 Views ↗

January 06, 2022

Following the market opening Thursday, the Dow traded down 0.52% to 36,217.32 while the NASDAQ fell 1.09% to 14,935.90. The S&P also fell, dropping 0.52% to 4,676.00. The U.S...

Via Benzinga

The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More ↗

November 08, 2021

Biotech stocks reversed course and closed the week ended Nov. 5 lower, squandering the gains notched early in the week. What was good news for Pfizer, Inc. (NYSE: PFE) turned out...

Via Benzinga

Mid-Afternoon Market Update: Dow Gains 100 Points; NovoCure Shares Plunge ↗

July 01, 2021

Toward the end of trading Thursday, the Dow traded up 0.29% to 34,603 while the NASDAQ rose 0.01% to 14,504.68. The S&P also rose, gaining 0.44% to 4,316.39. The U.S. has the...

Via Benzinga

Topics Stocks

The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO ↗

November 04, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck's Oral Antiviral COVID-19 Pill Authorized In UK Merck &...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

July 01, 2021

Gainers Alterity Therapeutics (NASDAQ:ATHE

Via Benzinga

The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline ↗

October 31, 2021

Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2021 ↗

September 09, 2021

Upgrades According to Benchmark, the prior rating for TopBuild Corp (NYSE:

Via Benzinga

Mid-Day Market Update: Crude Oil Rises Over 2%; Aligos Therapeutics Shares Slide ↗

July 01, 2021

Midway through trading Thursday, the Dow traded up 0.20% to 34,571.92 while the NASDAQ fell 0.24% to 14,468.72. The S&P also rose, gaining 0.24% to 4,307.60 The U.S. has the...

Via Benzinga

Topics Stocks

The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs ↗

August 01, 2021

Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies. Most pharma majors reported strong quarterly results....

Via Benzinga

58 Biggest Movers From Yesterday ↗

July 02, 2021

Gainers The Glimpse Group, Inc. (NASDAQ: VRAR) shares jumped 152.3% to settle at $17.66 on Thursday after the company priced its IPO at $7 per share. Pop Culture Group Co., Ltd (...

Via Benzinga

Topics Initial Public Offering

30 Stocks Moving In Thursday's Mid-Day Session ↗

July 01, 2021

Gainers Pop Culture Group Co., Ltd (NASDAQ: CPOP) shares jumped 104.6% to $62.00. Pop Culture Group shares jumped 405% on Wednesday after the company priced its IPO at $6 per...

Via Benzinga

Topics Initial Public Offering

Aligos Therapeutics Raises $84M Via Equity At 7% Discount ↗

July 01, 2021

Aligos Therapeutics Inc (NASDAQ: ALGS) has priced a previously announced underwritten public offering of 4.4 million shares at $19 per share, representing a...

Via Benzinga

58 Biggest Movers From Yesterday ↗

June 30, 2021

Gainers BSQUARE Corporation (NASDAQ: BSQR) shares jumped 206.9% to close at $8.04 on Tuesday on abnormally-high volume possibly amid increased attention from retail investors....

Via Benzinga

35 Stocks Moving In Tuesday's Mid-Day Session ↗

June 29, 2021

Gainers Cerevel Therapeutics Holdings, Inc. (NASDAQ: CERE) shares jumped 111.5% to $26.58 after the company announced positive results from its Phase 1b clinical trial of CVL-231...

Via Benzinga

Aligos Therapeutics Presses Capital Raise Button ↗

June 29, 2021

Aligos Therapeutics Inc (NASDAQ: ALGS) commenced an underwritten public offering of 4 million shares of common stock. Underwriters can purchase up to an...

Via Benzinga

The Daily Biotech Pulse: Sanofi Bets Big On mRNA Tech, Decision Day For MediWound, DiaMedica Issues Kidney Disease Data Readout ↗

June 29, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 28) Alexion Pharmaceuticals,...

Via Benzinga

22 Stocks Moving in Tuesday's Pre-Market Session ↗

June 29, 2021

Gainers Exela Technologies, Inc. (NASDAQ: XELA) rose 39% to $2.05 in pre-market trading after gaining over 5% on Monday. Marin Software Incorporated (NASDAQ: MRIN) rose 36.8% to...

Via Benzinga

The Daily Biotech Pulse: US To Procure 500M Pfizer-BioNTech Vaccine Doses For Donation, Verona Out-Licenses COPD Drug, Nautilus Lists Through SPAC Deal ↗

June 10, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 9) Aethlon Medical, Inc. (...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

May 12, 2021

Gainers Curis (NASDAQ:CRIS) shares moved upwards by 57.23% to $15.46 during Wednesday's regular session. Trading volume for Curis's stock is 28.8 million as of 12:...

Via Benzinga

The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings ↗

May 09, 2021

Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.